150 related articles for article (PubMed ID: 8355513)
1. Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.
Hwang WS; Chen LM; Huang SH; Wang CC; Tseng MT
Leuk Res; 1993 Aug; 17(8):685-8. PubMed ID: 8355513
[TBL] [Abstract][Full Text] [Related]
2. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
Pieters R; Loonen AH; Huismans DR; Broekema GJ; Dirven MW; Heyenbrok MW; Hählen K; Veerman AJ
Blood; 1990 Dec; 76(11):2327-36. PubMed ID: 2257305
[TBL] [Abstract][Full Text] [Related]
3. Relationship between in vitro chemosensitivity assessed with MTT assay and clinical outcomes in 103 patients with acute leukemia.
Jun KR; Jang S; Chi HS; Lee KH; Lee JH; Choi SJ; Seo JJ; Moon HN; Im HJ; Park CJ
Korean J Lab Med; 2007 Apr; 27(2):89-95. PubMed ID: 18094557
[TBL] [Abstract][Full Text] [Related]
4. An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia.
Hongo T; Fujii Y; Igarashi Y
Cancer; 1990 Mar; 65(6):1263-72. PubMed ID: 2306678
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
Kirkpatrick DL; Duke M; Goh TS
Leuk Res; 1990; 14(5):459-66. PubMed ID: 2345469
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
7. MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report.
Karakaş Z; Ağaoğlu L; Erdem S; Anak S; Hacibektaşoğlu A; Gedikoğlu G
Adv Exp Med Biol; 1999; 457():453-9. PubMed ID: 10500822
[No Abstract] [Full Text] [Related]
8. Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
Pieters R; Huismans DR; Leyva A; Veerman AJ
Br J Cancer; 1989 Feb; 59(2):217-20. PubMed ID: 2930687
[No Abstract] [Full Text] [Related]
9. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.
Sargent JM; Taylor CG
Br J Cancer; 1989 Aug; 60(2):206-10. PubMed ID: 2765367
[TBL] [Abstract][Full Text] [Related]
10. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias.
Kravtsov VD; Greer JP; Whitlock JA; Koury MJ
Blood; 1998 Aug; 92(3):968-80. PubMed ID: 9680366
[TBL] [Abstract][Full Text] [Related]
11. [Progress of chemotherapy in adult acute leukemia].
Ohno R
Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
[TBL] [Abstract][Full Text] [Related]
12. Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci.
Staib P; Lathan B; Schinköthe T; Wiedenmann S; Pantke B; Dimski T; Voliotis D; Diehl V
Adv Exp Med Biol; 1999; 457():437-44. PubMed ID: 10500820
[TBL] [Abstract][Full Text] [Related]
13. In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.
Klumper E; Pieters R; Kaspers GJ; Huismans DR; Loonen AH; Rottier MM; van Wering ER; van der Does-van den Berg A; Hählen K; Creutzig U
Leukemia; 1995 Nov; 9(11):1864-9. PubMed ID: 7475276
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.
Feldman EJ; Alberts DS; Arlin Z; Ahmed T; Mittelman A; Baskind P; Peng YM; Baier M; Plezia P
J Clin Oncol; 1993 Oct; 11(10):2002-9. PubMed ID: 8410125
[TBL] [Abstract][Full Text] [Related]
15. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
16. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
Savaşan S; Buck S; Ozdemir O; Hamre M; Asselin B; Pullen J; Ravindranath Y
Leuk Lymphoma; 2005 Jun; 46(6):833-40. PubMed ID: 16019527
[TBL] [Abstract][Full Text] [Related]
18. The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
Mihal V; Hajduch M; Noskova V; Janostakova A; Safarova M; Orel M; Kouzmina G; Stary J; Blazek B; Pospisilova D
Bull Cancer; 2004 Apr; 91(4):E80-9. PubMed ID: 15562558
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
[TBL] [Abstract][Full Text] [Related]
20. [Study on combined chemosensitivity test in acute non-lymphocytic leukemia].
Luo M; Bian S; Xue Y
Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):59-62. PubMed ID: 10921102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]